Figure 9. Graphical mechanistic hypothesis.
Cachexia‐mediated IL‐6 axis activation results in elevated catabolic signaling and disruption of WNT signaling in skeletal muscle. WNT dysfunction represents an apparent blockade of anabolic androgen signaling. Treatment with 10 mg/kg AR‐42 modulates IL‐6 axis activation and restores WNT responsiveness, promoting anabolism in skeletal muscle.